Meihua International Medical Technologies
MHUA
MHUA was delisted on the 8th of December, 2025.
6 hedge funds and large institutions have $489K invested in Meihua International Medical Technologies in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
76% more capital invested
Capital invested by funds: $278K → $489K (+$211K)
50% more funds holding
Funds holding: 4 → 6 (+2)
0% more ownership
Funds ownership: 0% → 0% (+0%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$646K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$79.3K |
| 3 |
Morgan Stanley
New York
|
+$18.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$39.6K |
| 2 |
Invesco
Atlanta,
Georgia
|
-$31.4K |
| 3 |
JP Morgan Chase
New York
|
-$3.3K |
| 4 |
Citigroup
New York
|
-$1.76K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $263K | +$646K | +391 | New |
|
|
2
Invesco
Atlanta,
Georgia
| $180K | -$31.4K | -19 | -6% |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $31K | +$79.3K | +48 | New |
|
|
4
Morgan Stanley
New York
| $7.11K | +$18.2K | +11 | New |
|
|
5
JP Morgan Chase
New York
| $7K | -$3.3K | -2 | -17% |
|
|
6
UBS Group
Zurich,
Switzerland
| $441 | -$39.6K | -24 | -96% |
|
7
Osaic Holdings
Scottsdale,
Arizona
| $6 | – | – | – |
|
|
8
Citigroup
New York
| – | -$1.76K | -2 | Closed |
|
MHUA Hedge Fund Activity: Q1 2023 in Review
6 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Meihua International Medical Technologies (MHUA) for Q1 2023, worth a combined $489K — up 76% from $278K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new MHUA positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 3 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $646K. The largest seller was UBS Group, cutting an estimated $39.6K.
- 6 institutional investors held Meihua International Medical Technologies (MHUA) as of Q1 2023, up from 4 in Q4 2022.
- Funds reported $489K of Meihua International Medical Technologies stock for Q1 2023, up 76% quarter-over-quarter.
- 3 funds opened new Meihua International Medical Technologies positions in Q1 2023 and 1 closed out, a net change of +2 holders.
- The largest Meihua International Medical Technologies buyer in Q1 2023 was Citadel Advisors, an estimated $646K added.
- The largest Meihua International Medical Technologies seller in Q1 2023 was UBS Group, an estimated $39.6K sold.
Based on aggregated 13F filings for Q1 2023.